Revolution Medicines (RVMD) Receivables - Other (2019 - 2020)
Revolution Medicines (RVMD) recorded quarterly Receivables - Other of $6.4 million in Q4 2020, down 31.25% quarter-over-quarter from $9.3 million in Q3 2020, and down 26.83% on a YoY basis from $8.7 million in Q1 2020.
Revolution Medicines (RVMD) Receivables - Other (2019 - 2020) Analysis & Trends
Revolution Medicines' Receivables - Other history runs 2 years deep, the most recent figure standing at $6.4 million for Q4 2020.
- In Q4 2020, Receivables - Other fell 26.83% year-over-year to $6.4 million; the TTM figure through Dec 2020 stood at $6.4 million (down 26.83% YoY), while the FY2020 annual figure was $6.4 million, down 26.83% from the prior year.
- Receivables - Other was $6.4 million for Q4 2020 at Revolution Medicines, down from $9.3 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $9.3 million in Q3 2020 to a low of $6.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 6.39 Mn |
| Dec 31, 2020 | 6.39 Mn |
| Sep 30, 2020 | 9.30 Mn |
| Sep 30, 2020 | 9.30 Mn |
| Jun 30, 2020 | 7.33 Mn |
| Jun 30, 2020 | 7.33 Mn |
| Mar 31, 2020 | 8.45 Mn |
| Mar 31, 2020 | 8.45 Mn |
| Dec 31, 2019 | 8.74 Mn |
| Dec 31, 2019 | 8.74 Mn |